Seyed Ali Nowbar, RPH
Pharmacist · Hollister
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Seyed Ali Nowbar’s office at (831) 630-3100 to ask if they take your plan before you enroll.
California Medical Board record
Licence A45567 · Current
Licensed to practise in California · since 1988 · expires 2028-10-31 · National Taiwan University College of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$27,769
Pharmacies billed $27,769 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 140) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
0 generic and 140 brand-name prescriptions · $27,769 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Abrysvo | 50 | $12,388 | $248 |
| Shingrix | 47 | $9,366 | $187 |
| Arexvy | 12 | $3,515 | $293 |
| Boostrix Tdap | 25 | $1,563 | $63 |
Year by year
| 2024 | 140 | 120 | 0% (0) | 100% | $27,769 |
| 2023 | 173 | 144 | 0% (0) | 100% | $44,599 |
| 2022 | 73 | 56 | 0% (0) | 97% | $12,850 |
| 2021 | 32 | 24 | 0% (0) | 100% | $5,057 |
| 2020 | 43 | 31 | 0% (0) | 100% | $6,715 |
| 2019 | 43 | 34 | 0% (0) | 100% | $5,982 |
| 2018 | 26 | 20 | 0% (0) | 100% | $4,117 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Shingrix | 78 | $16,946 | $217 |
| Abrysvo | 40 | $13,497 | $337 |
| Arexvy | 41 | $13,057 | $318 |
| Boostrix Tdap | 12 | $833 | $69 |
2022: 1 drug
| Shingrix | 59 | $11,699 | $198 |
2021: 1 drug
| Shingrix | 24 | $4,526 | $189 |
2020: 1 drug
| Shingrix | 35 | $6,206 | $177 |
2019: 2 drugs
| Shingrix | 31 | $5,201 | $168 |
| Boostrix Tdap | 11 | $682 | $62 |
2018: 1 drug
| Shingrix | 20 | $3,314 | $166 |
Professional record
- NPI
- 1992978431
- Licence
- CA 45567California A45567: Current · expires 2028-10-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 581 Mccray St # A, Hollister, CA, 95023
- NPI first listed
- 2008-04-04
- NPI last updated
- 2026-01-28
- NPI record certified
- 2026-01-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2882 Birkdale Ct, Gilroy, CA, 95020